Latest News

LSTM led partnership receives funding to develop drug for treating two neglected tropical diseases

An LSTM led partnership has been awarded nearly £1.5 million from the Medical Research Council for the pre-clinical development of a candidate drug to treat onchocerciasis and lymphatic filariasis, by targeting the bacterial symbiont Wolbachia.

Source link




Related posts

US Lifts Visa Halt to Boost COVID-19 Physician Workforce

Newsemia

Alcohol-related cirrhosis mortality on the rise among young adults

Newsemia

Medical News Today: What causes rosy cheeks?

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy